NL
DE
Patient must give explicit consent
A lot of scientific research is carried out at the Radboudumc. This is necessary to develop new and improved treatments for our patients. With patients' consent, we can use their medical data, leftover biomaterial (such as blood, urine or tissue) and images for scientific research and education.
A conscious choice
In the past, obtaining consent from patients was arranged via the opt-out method. This meant that medical data and remaining biomaterial and images were accessible to researchers unless the patient explicitly objected. However, many patients were not aware that their medical data and material could be used for scientific research. To improve the consent procedure, the NFU decided to run a trial with the opt-in method, in which the Radboudumc participates. With this method, the patient is explicitly asked for permission in advance. This consent procedure will apply from January 2020 for all new patients who register as a patient at Radboudumc for the first time. Until further notice, the opt-in method will be used.
How do we request permission now?
New eligible patients will be asked for their consent when registering at the central registration desk. The answer is immediately registered in Epic. Sometimes a patient is not approached at the central registration desk. In this case, the patient receives a request via mijnRadboud or a letter at home. Patients can always adjust the choice made via mijnRadboud or via the reception desk staff.
Will this affect my research?
When using medical data from patient records or leftover biomaterial and images, you should always check the patient's current consent status in Epic. If a patient has objected or has not responded, you will not be able to use the patient's data and material. A patient can change their status at any time, so it is important to regularly check the consent status in the system.
More information
You will find more information for patients (in Dutch) about the use of medical data and leftover biomaterial at the Radboudumc here .
Contact person: Jennifer Lutomski, Radboud Biobank.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Joint research in regional hospitals New research projects from promotion fund
22 November 2022Four research projects have been honored in the promotion fund of the Radboudumc and four regional hospitals. The research projects, which are a collaboration between CWZ, Jeroen Bosch Hospital, Rijnstate, Sint Maartenskliniek and the Radboudumc will receive a contribution of 240,000 euros.
read more
New Radboudumc PhD thesis guidelines & Rules composition Manuscript Committee
8 November 2022The new PhD guidelines replace the current 2019 guidelines and are applicable to anyone pursuing a doctoral degree within the medical faculty (including PhD candidates that are currently participating in the Donders Graduate school). The guidelines are now available.
read more
L’Oréal-Unesco For Women in Science grants now open to researchers in Life Sciences and STEM disciplines
8 November 2022The eleventh call for applications of the Dutch L’Oréal-Unesco For Women in Science fellowships opens on 16 January 2023. But this year, it’s a little different: next to researchers in Life Sciences, women working in the STEM disciplines can also apply.
read more
Dutch-Nordic Alliance for Precision Cancer Medicine launched
26 November 2021 The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands. read more
